1. Home
  2. MTA vs CTKB Comparison

MTA vs CTKB Comparison

Compare MTA & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTA
  • CTKB
  • Stock Information
  • Founded
  • MTA 1983
  • CTKB 1990
  • Country
  • MTA Canada
  • CTKB United States
  • Employees
  • MTA N/A
  • CTKB N/A
  • Industry
  • MTA
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MTA
  • CTKB Health Care
  • Exchange
  • MTA Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • MTA 391.4M
  • CTKB 430.6M
  • IPO Year
  • MTA N/A
  • CTKB 2021
  • Fundamental
  • Price
  • MTA $4.30
  • CTKB $4.03
  • Analyst Decision
  • MTA Hold
  • CTKB Hold
  • Analyst Count
  • MTA 1
  • CTKB 4
  • Target Price
  • MTA $4.50
  • CTKB $6.00
  • AVG Volume (30 Days)
  • MTA 359.0K
  • CTKB 1.1M
  • Earning Date
  • MTA 08-18-2025
  • CTKB 08-06-2025
  • Dividend Yield
  • MTA N/A
  • CTKB N/A
  • EPS Growth
  • MTA N/A
  • CTKB N/A
  • EPS
  • MTA N/A
  • CTKB N/A
  • Revenue
  • MTA $6,348,000.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • MTA $115.15
  • CTKB $0.74
  • Revenue Next Year
  • MTA $71.94
  • CTKB $7.85
  • P/E Ratio
  • MTA N/A
  • CTKB N/A
  • Revenue Growth
  • MTA 30.38
  • CTKB N/A
  • 52 Week Low
  • MTA $2.45
  • CTKB $2.37
  • 52 Week High
  • MTA $4.34
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • MTA 60.21
  • CTKB 65.71
  • Support Level
  • MTA $4.15
  • CTKB $3.80
  • Resistance Level
  • MTA $4.33
  • CTKB $4.19
  • Average True Range (ATR)
  • MTA 0.16
  • CTKB 0.21
  • MACD
  • MTA -0.01
  • CTKB 0.06
  • Stochastic Oscillator
  • MTA 91.35
  • CTKB 85.45

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: